Nematicides MarketSize, Share & Industry Analysis, 2026-2034By Product TypeBy Mode of ActionBy Crop TypeBy Application MethodBy FormulationBy Target NematodeBy Cultivation SystemBy Farming PracticeBy Distribution ChannelBy End User
Full title & scope — all 10 axes with their segments
Nematicides Market Size, Share & Industry Analysis, By Product Type (Fumigants, Organophosphates and Carbamates, Novel Synthetic Chemistries, Microbial Biological Nematicides, Botanical and Natural Extracts), By Mode of Action (Contact, Systemic, Soil Fumigant Action, Biological Antagonism), By Crop Type (Fruits and Vegetables, Cereals and Grains, Oilseeds and Pulses, Turf and Ornamentals, Other Crops), By Application Method (Soil Treatment, Seed Treatment, Chemigation, Foliar Application), By Formulation (Liquid, Granular, Powder and Wettable Powder, Gas), By Target Nematode (Root-Knot Nematodes, Cyst Nematodes, Lesion Nematodes, Reniform Nematodes, Other Plant-Parasitic Nematodes), By Cultivation System (Open Field, Protected Cultivation, Orchards and Plantations), By Farming Practice (Conventional Farming, Organic Farming, Integrated Pest Management), By Distribution Channel (Direct Sales to Growers, Distributors and Agri-retailers, Cooperatives, Online Channels), By End User (Large Commercial Growers, Smallholder Farmers, Turf and Landscape Managers, Custom Applicators), and Regional Forecast, 2026-2034
Market outlook, key takeaways, drivers and challenges for the report period.
- 01By Product TypeFumigants · Organophosphates and Carbamates · Novel Synthetic Chemistries
- 02By Mode of ActionContact · Systemic · Soil Fumigant Action
- 03By Crop TypeFruits and Vegetables · Cereals and Grains · Oilseeds and Pulses
- 04By Application MethodSoil Treatment · Seed Treatment · Chemigation
- 05By FormulationLiquid · Granular · Powder and Wettable Powder
- 06By Target NematodeRoot-Knot Nematodes · Cyst Nematodes · Lesion Nematodes
- 07By Cultivation SystemOpen Field · Protected Cultivation · Orchards and Plantations
- 08By Farming PracticeConventional Farming · Organic Farming · Integrated Pest Management
- 09By Distribution ChannelDirect Sales to Growers · Distributors and Agri-retailers · Cooperatives
- 10By End UserLarge Commercial Growers · Smallholder Farmers · Turf and Landscape Managers
- 11By Region
Market Analysis & Outlook
Nematicides are crop protection products that control plant-parasitic nematodes, microscopic worms that feed on roots and cut the yield and quality of vegetables, fruit, cereals, oilseeds, turf and ornamentals. The category covers soil fumigants, organophosphate and carbamate chemistries, newer synthetic actives, and microbial and botanical biological products, applied to soil, seed or through irrigation in liquid, granular, powder and gas forms. Buyers are commercial and smallholder growers, custom applicators and turf managers, usually served through distributors, retailers and cooperatives.
The global nematicides market is valued at USD 2.05 billion in 2025 and is set to reach USD 3.55 billion by 2034, a compound annual growth rate of 6.29% across the 2026-2034 forecast period. The study tracks the market across USD 1.52 billion in 2020, USD 1.94 billion in 2024, USD 2.18 billion in 2026 and USD 2.8 billion in 2030.
36% of 2025 revenue sits in Fumigants, worth USD 0.738 billion and rising to USD 1.086 billion at 30.6% by 2034, the largest product type line in both years. Growth is fastest in Microbial Biological Nematicides at 12.24% and slowest in Organophosphates and Carbamates at -0.06%. Novel Synthetic Chemistries, Microbial Biological Nematicides and Botanical and Natural Extracts take share over the period; Fumigants and Organophosphates and Carbamates give it up while still growing in absolute terms.
Cut by mode of action, the largest line is Soil Fumigant Action: 36% of 2025 revenue, worth USD 0.738 billion, and 30% at USD 1.065 billion by 2034. Biological Antagonism grows faster at 13.48% against 4.16%, moving from 15% of revenue to 27% by 2034. Both this axis and the product type one divide the same revenue, which is why they are alternative views, not components.
The regional order runs from Asia Pacific at 34% of 2025 revenue down to Middle East and Africa at 7%. Asia Pacific is worth USD 0.697 billion in 2025 and USD 1.367 billion in 2034; North America, second at 27%, moves from USD 0.553 billion to USD 0.862 billion. Because Asia Pacific and Latin America take share, the revenue added by 2034 concentrates instead of spreading across all five regions.
The 2025 total is arrived at by triangulating published aggregates against category proxies, not by an independent count. Segment, regional and country splits are estimated on the same basis, which bounds the precision of the figures above. Coverage runs to five regions, five product type lines and ten segmentation axes across a fifteen-year window.
Market Size, 2020–2034
USD BillionRevenue in USD Billion. Values up to 2025 are actuals; 2026–2034 are forecast.
Key Takeaways
- The global nematicides market moves from USD 1.52 billion in 2020 to USD 2.05 billion in 2025 and USD 3.55 billion by 2034, the forecast period compounding at 6.29% a year.
- The largest line by product type is Fumigants, worth USD 0.738 billion and 36% of revenue in 2025, rising to USD 1.086 billion and 30.6% by 2034.
- Fastest growth on the product type axis belongs to Microbial Biological Nematicides: 12.24% a year, USD 0.307 billion to USD 0.884 billion, and a share moving from 15% to 24.9%.
- Scenario range for 2034 runs from USD 3.07 billion in the bear case to USD 4.05 billion in the bull case, against a base-case USD 3.55 billion, the spread a plan built on this forecast has to absorb.
- Asia Pacific holds 34% of global revenue in 2025 at USD 0.697 billion, the largest of the five regions tracked, and reaches USD 1.367 billion by 2034.
- 32.28% of Asia Pacific's base-year revenue comes from China alone: USD 0.225 billion in 2025, rising to USD 0.415 billion by 2034, which is why it is that region's worked example.
- The study covers 2020 through 2034 with 2025 as the base year, reporting five regions and ten segmentation axes separately, with revenue, share and a growth rate for every line in each year.
Market Trends
Revenue Share, By product type
Base year 2025Fumigants leads with 36.0% of product type segment revenue.
Share of product type segment revenue, most recent base year.
Three things move over 2026-2034, and they are worth separating: the product type mix, the regional balance, and the 6.29% compounding underneath both.
The direction of the market is not in question in any of the three. Each line and each region grows in revenue terms; what separates them is which takes the larger part of the growth.
Composition shifts on the product type axis. Microbial Biological Nematicides grows at 12.24% across 2026-2034 against -0.06% for Organophosphates and Carbamates, the widest spread on the product type axis. Microbial Biological Nematicides takes its share of revenue from 15% to 24.9% while Organophosphates and Carbamates gives up ground, from 28% to 16.3%. Revenue rises on both sides; USD 0.307 billion to USD 0.884 billion and USD 0.574 billion to USD 0.579 billion respectively, so this is a change in composition, not a contraction, and one forecast window is long enough for it to matter.
Growth concentrates in Asia Pacific and Latin America. Asia Pacific moves from 34% of revenue in 2025 to 38.5% in 2034, worth USD 0.697 billion rising to USD 1.367 billion; Latin America moves from 15% of revenue in 2025 to 15.9% in 2034, worth USD 0.307 billion rising to USD 0.564 billion. Against that, North America at 27% moving to 24.3%, Europe at 17% moving to 14.3%, Middle East and Africa at 7% moving to 7%, a fall in share, not in revenue. Growth is therefore not something a participant inherits from the market; it depends on which regions its revenue is weighted toward.
Fifteen years without a discontinuity. The market moves through USD 1.52 billion in 2020, USD 1.94 billion in 2024, USD 2.05 billion in 2025, USD 2.18 billion in 2026, USD 2.8 billion in 2030 and USD 3.55 billion in 2034. The forecast rate of 6.29% sits against 6.17% over the historical period, so the projection extends an observed trend instead of proposing a new one. That moves the planning question away from timing a turn and onto the product type and regional mixes, where the actual movement is.
Market Growth Factors
Microbial Biological Nematicides adds the most incremental growth
Market Drivers
3- 01Microbial Biological Nematicides adds the most incremental growth
At 12.24% against a market rate of 6.29%, Microbial Biological Nematicides is the line pulling the average up: USD 0.307 billion to USD 0.884 billion, and 15% of revenue to 24.9%. Set against -0.06% at the other end of the axis, this is the line that decides whether the market's 6.29% holds. Exposure to this line, not to the market as a whole, is what determines a supplier's own rate.
- 02Asia Pacific carries 34% of the base and keeps growing
The largest regional base is Asia Pacific: USD 0.697 billion in 2025 at 34% of the global total, USD 1.367 billion by 2034 and 38.5%. North America adds a further 27% at USD 0.553 billion, reaching USD 0.862 billion. Most of the base and most of the growth sit in those two, and a plan spread evenly across regions therefore over-invests outside them.
- 03A demonstrated trajectory, not a projected turnaround
USD 1.52 billion in 2020, USD 1.94 billion in 2024 and USD 2.05 billion in 2025: 6.17% compound growth before the forecast period even begins. The forecast period then runs at 6.29%, ending 2034 at USD 3.55 billion. Fifteen years of unbroken growth in the series means the forecast rests on a demonstrated trajectory, not a projected turnaround, and it is why the 6.29% rate is applied flat across the whole period instead of ramped through it.
Growth drivers
| # | Growth driver | Impact | Gross contribution (USD Billion) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Rising plant-parasitic nematode pressure in intensive horticulture | High | +0.55 | High | High | Medium |
| 2 | Shift to biological and novel synthetic chemistries as older actives are restricted | High | +0.5 | Medium | High | High |
| 3 | Expansion of protected cultivation and high-value vegetable and fruit area | Medium-High | +0.35 | High | Medium | Medium |
| 4 | Wider soil and seed treatment in Asia Pacific and Latin America | Medium-High | +0.3 | Medium | High | High |
| 5 | Integrated pest management programmes among commercial growers and custom applicators | Medium | +0.15 | Medium | Medium | Medium |
| 6 | Others | Low | +0.1 | Low | Low | Low |
| Total | +1.95 | |||||
Restraints
| # | Restraint | Impact | Estimated reduction (USD Billion) | 2026-28 | 2029-31 | 2032-34 |
|---|---|---|---|---|---|---|
| 1 | Regulatory withdrawal of fumigants and carbamates | High | −0.25 | High | High | Medium |
| 2 | Slower grower uptake of biological products on variable field performance and cost | Medium | −0.12 | Medium | Medium | Low |
| 3 | Registration cost and approval timelines for new actives | Medium | −0.08 | Medium | Low | Low |
| Total | −0.45 | |||||
Drivers contribute 1.95 USD Billion and restraints remove 0.45 USD Billion, a net 1.5 USD Billion, which is the revenue the market adds between the base year and 2034. Contributions are CDI estimates, apportioned so that they reconcile with the forecast rather than being read from it.
Three sources account for the growth to 2034: 6.29% compounding across the base, share moving toward the faster product type lines, and above-market expansion in the leading regions.
Restraining Factors
The bear case and what drives it
Market Restraints
2- 01The bear case and what drives it
Biological uptake stalls on variable performance, registration delays hold back new actives, and weak crop prices cut grower spending on soil protection. On that assumption 2034 revenue lands at USD 3.07 billion against the USD 3.55 billion base case, from the same USD 2.05 billion 2025 starting point.
- 02Fumigants holds the blended rate down
Fumigants carries 36% of 2025 revenue at USD 0.738 billion but compounds at 4.36% against 6.29% for the market, taking its share to 30.6% by 2034 even as revenue rises to USD 1.086 billion. Because it carries that much of the base, its pace holds the blended rate down more than any faster line lifts it.
Market Opportunities
Where the forecast could be beaten
Market Opportunities
2- 01Where the forecast could be beaten
The upside path assumes fumigant restrictions push growers to newer chemistries faster, biological products show consistent field results, and treated area in Asia Pacific and Latin America expands quickly. It ends 2034 at USD 4.05 billion against a USD 3.55 billion base case, off the same USD 2.05 billion base year.
- 02The opening is on the product type axis, not the regional one
Share on the product type axis moves toward Microbial Biological Nematicides, from 15% in 2025 to 24.9% in 2034, on 12.24% growth against the market's 6.29% and revenue rising from USD 0.307 billion to USD 0.884 billion. Taking position there does not require displacing whoever holds Fumigants, which is the harder and more expensive fight.
Market Challenges
The total depends on a single line
Market Challenges
2- 01The total depends on a single line
Fumigants is 36% of 2025 revenue at USD 0.738 billion and still 30.6% at USD 1.086 billion in 2034. No other single change on the product type axis moves the total as much as a change in demand for that one line.
- 02Asia Pacific is largely China
32.28% of the leading region is one country: China, at USD 0.225 billion against Asia Pacific's USD 0.697 billion in 2025, and USD 0.415 billion by 2034. The consequence is that regional risk here is really country risk wearing a larger label.
Segmentation Analysis
10 axesten segmentation axes are reported; by product type, by mode of action, crop type, application method, formulation, target nematode, cultivation system, farming practice, distribution channel and end user. Revenue does not add across them: each is a different cut of the same total.
All five product type lines expand in revenue terms over the forecast period. Share is the dividing line; three take it, the others cede it.
By Product Type · 5 segments
Microbial Biological Nematicides Outpaces the Axis While Fumigants Holds the Largest Share
- Largest Fumigants · 36%
- Fastest Microbial Biological Nematicides · 12.2%
- Moves most Organophosphates and Carbamates · -11.7 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Fumigants | $0.74B | 36% | $1.09B | 30.6%-5.4 | 4.4% |
| Organophosphates and Carbamates | $0.57B | 28% | $0.58B | 16.3%-11.7 | -0.1% |
| Novel Synthetic Chemistries | $0.29B | 14% | $0.72B | 20.3%+6.3 | 10.7% |
| Microbial Biological Nematicides | $0.31B | 15% | $0.88B | 24.9%+9.9 | 12.2% |
| Botanical and Natural Extracts | $0.14B | 7% | $0.28B | 7.9%+0.9 | 7.7% |
Fumigants lead because they remain the established answer for pre-plant soil disinfestation in high-value vegetable and fruit systems, where growers need broad and fast control. Microbial biological nematicides grow fastest as restrictions on older chemistries push buyers toward products that fit residue limits and integrated programmes, helped by wider commercial availability and retailer advisory support. By 2034 Fumigants is still ahead, making this a shift in weight, not a change of leader. Every year of the series is priced on this axis, making it the reference cut for the rest of the report.
By Mode of Action · 4 segments
Soil Fumigant Action Led by Mode of action in 2025, with Biological Antagonism Growing Fastest
- Largest Soil Fumigant Action · 36%
- Fastest Biological Antagonism · 13.5%
- Moves most Biological Antagonism · +12 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Contact | $0.45B | 22% | $0.53B | 15%-7 | 1.9% |
| Systemic | $0.55B | 27% | $0.99B | 28%+1 | 6.7% |
| Soil Fumigant Action | $0.74B | 36% | $1.06B | 30%-6 | 4.2% |
| Biological Antagonism | $0.31B | 15% | $0.96B | 27%+12 | 13.5% |
Soil fumigant action leads because gaseous products reach nematodes through the whole root zone before planting, which suits intensive horticulture. Biological antagonism grows fastest as microbes that colonise roots and crowd out parasites gain acceptance in programmes that must meet residue limits. Contact products lose ground where regulators restrict older chemistries and systemic options give longer protection. The order does not change: Soil Fumigant Action is still largest in 2034, and what moves is how much it holds.
By Crop Type · 5 segments
Oilseeds and Pulses Outpaces the Axis While Fruits and Vegetables Holds the Largest Share
- Largest Fruits and Vegetables · 44%
- Fastest Oilseeds and Pulses · 8.6%
- Moves most Fruits and Vegetables · -3 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Fruits and Vegetables | $0.90B | 44% | $1.46B | 41%-3 | 5.5% |
| Cereals and Grains | $0.35B | 17% | $0.68B | 19%+2 | 7.6% |
| Oilseeds and Pulses | $0.29B | 14% | $0.60B | 17%+3 | 8.6% |
| Turf and Ornamentals | $0.27B | 13% | $0.39B | 11%-2 | 4.3% |
| Other Crops | $0.25B | 12% | $0.43B | 12% | 6.3% |
Fruits and vegetables lead because high-value crops justify the cost of soil treatment and suffer large losses from root damage. Oilseeds and pulses grow fastest as soybean and pulse area expands in warm regions with rising nematode pressure and growers begin to protect yield with seed-applied products. Turf and ornamentals grow slowest, held back by limited area and product restrictions in urban settings. Fruits and Vegetables remains the largest line through 2034, so the axis changes in proportion, not in order.
By Application Method · 4 segments
Soil Treatment Held the Dominant Share of the Application method Segment in 2025
- Largest Soil Treatment · 62%
- Fastest Seed Treatment · 10%
- Moves most Soil Treatment · -8 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Soil Treatment | $1.27B | 62% | $1.92B | 54%-8 | 4.7% |
| Seed Treatment | $0.29B | 14% | $0.68B | 19%+5 | 10% |
| Chemigation | $0.31B | 15% | $0.64B | 18%+3 | 8.4% |
| Foliar Application | $0.18B | 9% | $0.32B | 9% | 6.3% |
Soil treatment leads because nematodes live in the root zone, and pre-plant and at-plant applications remain the standard way to reach them. Seed treatment grows fastest as low-dose products applied before sowing cut labour and application cost, and suit large-area crops where soil fumigation is impractical. Foliar application stays small because it cannot reach soil-borne parasites directly. Soil Treatment remains the largest line through 2034, so the axis changes in proportion, not in order.
By Formulation · 4 segments
Scale and Growth Sit in the Same Line on the Formulation Axis: Liquid
- Largest Liquid · 38%
- Fastest Liquid · 7.8%
- Moves most Liquid · +5 pts
- Order by 2034 changes
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Liquid | $0.78B | 38% | $1.53B | 43%+5 | 7.8% |
| Granular | $0.49B | 24% | $0.82B | 23%-1 | 5.8% |
| Powder and Wettable Powder | $0.25B | 12% | $0.43B | 12% | 6.3% |
| Gas | $0.53B | 26% | $0.78B | 22%-4 | 4.3% |
Liquid products lead because they suit drip, drench and in-furrow application and are easy to mix and meter on commercial farms. They also grow fastest, as most new biological and synthetic launches come in liquid or suspension form. Gas formulations lose share as fumigant restrictions tighten, while powders keep a steady niche where storage stability and low-cost handling matter. Liquid remains the largest line through 2034, so the axis changes in proportion, not in order.
By Target Nematode · 5 segments
Scale in Root-Knot Nematodes and Growth in Reniform Nematodes Define the Target nematode Axis
- Largest Root-Knot Nematodes · 46%
- Fastest Reniform Nematodes · 7.7%
- Moves most Root-Knot Nematodes · -2 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Root-Knot Nematodes | $0.94B | 46% | $1.56B | 44%-2 | 5.8% |
| Cyst Nematodes | $0.37B | 18% | $0.68B | 19%+1 | 6.9% |
| Lesion Nematodes | $0.29B | 14% | $0.50B | 14% | 6.3% |
| Reniform Nematodes | $0.16B | 8% | $0.32B | 9%+1 | 7.7% |
| Other Plant-Parasitic Nematodes | $0.29B | 14% | $0.50B | 14% | 6.3% |
Root-knot nematodes lead because they attack a very wide range of vegetables, fruits and field crops across warm climates, so they set the main demand for control. Reniform nematodes grow fastest as cotton and soybean growers in warm regions face spreading infestations and look for chemistry beyond crop rotation, while lesion and other parasites follow overall demand. Root-Knot Nematodes remains the largest line through 2034, so the axis changes in proportion, not in order.
By Cultivation System · 3 segments
Open Field Led by Cultivation system in 2025, with Protected Cultivation Growing Fastest
- Largest Open Field · 58%
- Fastest Protected Cultivation · 9.2%
- Moves most Open Field · -6 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Open Field | $1.19B | 58% | $1.85B | 52%-6 | 5% |
| Protected Cultivation | $0.45B | 22% | $0.99B | 28%+6 | 9.2% |
| Orchards and Plantations | $0.41B | 20% | $0.71B | 20% | 6.3% |
Open field leads because most nematicide-treated area is still in broad-area and row-crop production. Protected cultivation grows fastest, since repeated cropping in the same greenhouse or tunnel soil builds nematode populations quickly, and growers there accept higher treatment costs to protect high-value harvests. Orchards and plantations grow steadily as replanting programmes need soil protection for young trees. By 2034 Open Field is still ahead, making this a shift in weight, not a change of leader.
By Farming Practice · 3 segments
Conventional Farming Led by Farming practice in 2025, with Organic Farming Growing Fastest
- Largest Conventional Farming · 66%
- Fastest Organic Farming · 11.6%
- Moves most Conventional Farming · -12 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Conventional Farming | $1.35B | 66% | $1.92B | 54%-12 | 4% |
| Organic Farming | $0.18B | 9% | $0.50B | 14%+5 | 11.6% |
| Integrated Pest Management | $0.51B | 25% | $1.14B | 32%+7 | 9.3% |
Conventional farming leads because it covers the bulk of treated area and the largest grower base, and it relies on registered synthetic chemistries and fumigants. Organic farming grows fastest from a small base as certified growers face the same nematode losses with few approved tools, which draws demand to biological and botanical products. Integrated pest management programmes expand as retailers and advisers bundle products. By 2034 Conventional Farming is still ahead, making this a shift in weight, not a change of leader.
By Distribution Channel · 4 segments
Online Channels Outpaces the Axis While Distributors and Agri-retailers Holds the Largest Share
- Largest Distributors and Agri-retailers · 55%
- Fastest Online Channels · 16.3%
- Moves most Distributors and Agri-retailers · -7 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Direct Sales to Growers | $0.49B | 24% | $0.89B | 25%+1 | 6.8% |
| Distributors and Agri-retailers | $1.13B | 55% | $1.70B | 48%-7 | 4.7% |
| Cooperatives | $0.35B | 17% | $0.64B | 18%+1 | 7% |
| Online Channels | $0.08B | 4% | $0.32B | 9%+5 | 16.3% |
Distributors and agri-retailers lead because they hold the grower relationship, credit terms and local agronomy advice that most buyers depend on at purchase. Online channels grow fastest from a very small base as growers become used to ordering inputs digitally and suppliers test direct delivery. Direct sales stay important for large growers who negotiate volume contracts and technical support. By 2034 Distributors and Agri-retailers is still ahead, making this a shift in weight, not a change of leader.
By End User · 4 segments
Scale in Large Commercial Growers and Growth in Smallholder Farmers Define the End user Axis
- Largest Large Commercial Growers · 41%
- Fastest Smallholder Farmers · 7.3%
- Moves most Smallholder Farmers · +2 pts
- Order by 2034 unchanged
| Segment | 2025 | Share | 2034 | Share | CAGR |
|---|---|---|---|---|---|
| Large Commercial Growers | $0.84B | 41% | $1.42B | 40%-1 | 6% |
| Smallholder Farmers | $0.45B | 22% | $0.85B | 24%+2 | 7.3% |
| Turf and Landscape Managers | $0.25B | 12% | $0.35B | 10%-2 | 4.2% |
| Custom Applicators | $0.51B | 25% | $0.92B | 26%+1 | 6.8% |
Large commercial growers lead because they farm the greatest treated area and can afford fumigation and programmes that combine several products. Smallholder farmers grow fastest as extension services, cooperative schemes and smaller pack sizes bring nematode control within reach in Asia and Africa. Turf and landscape managers grow slowest, limited by tight product rules in public and residential areas. By 2034 Large Commercial Growers is still ahead, making this a shift in weight, not a change of leader.
Regional Insights
Regional Revenue Share
Base year 2025Share of global revenue in the base year.
Only the leading region's share is published outside the report; pins mark the region, not a specific country.
North America Market Analysis
The 2nd-largest region covered — 2.7 points of share move elsewhere by 2034.
- Rank 2 of 5
- 2025 share 27%
- By 2034 24.3%
- Revenue $0.55B → $0.86B
North America holds 27% of the global nematicides market in 2025, worth USD 0.553 billion rising to USD 0.862 billion in 2034. By revenue it sits second across the study, and the ranking does not change between 2025 and 2034.
Share settles at 24.3% in 2034, while nothing contracts here; other regions simply grow faster, which shows up as relative weight, not as falling revenue.
Segment composition follows the global pattern: Fumigants largest at 36% of 2025 revenue, Microbial Biological Nematicides fastest at 12.24%. The full report breaks North America out along every axis and by country.
United States
Sets the pace for North America at 79.6% of it, growing 1.6×.
- In region 1 of 3
- Of region 79.6%
- Of global 21.5%
- Revenue $0.44B → $0.69B
79.57% of North America's base-year revenue comes from the United States; USD 0.44 billion, rising to USD 0.69 billion by 2034. Because it is 79.57% of the region in the base year, North America's totals move with this one country instead of a spread of them. Set against USD 0.553 billion and USD 0.862 billion for the region, it is why this market, and not a smaller one, is the one reported in full.
the United States buys along the same lines as the market globally; Fumigants first at 36% of 2025 revenue and 30.6% in 2034, Microbial Biological Nematicides fastest at 12.24% on a share moving from 15% to 24.9%. Its 79.57% weight in North America means those movements carry straight into the regional totals. Revenue by product type for the United States is reported separately in the full report.
Nematicides sold in the United States are pesticides under the Federal Insecticide, Fungicide, and Rodenticide Act, administered by the Environmental Protection Agency. A supplier must register each product before distribution, supplying toxicology, environmental fate and efficacy data for the active ingredient and the formulated product. The agency may classify a product as restricted use, which limits purchase and application to certified applicators. Labels are legally binding and must carry directions for use, worker protection statements, and environmental hazard warnings. State agencies add their own registration step, and California applies its own review through the Department of Pesticide Regulation.
Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc. and Ishihara Sangyo Kaisha, Ltd. are the suppliers covered in the United States. Volume sits in Fumigants at 36% of 2025 revenue; movement sits in Microbial Biological Nematicides at 12.24% growth. Country-level positioning and shares for each of these companies are part of the full report, not of this summary.
Canada
2nd-largest in North America, growing 1.5×.
- In region 2 of 3
- Of region 10.5%
- Of global 2.8%
- Revenue $0.06B → $0.09B
Within North America, Canada accounts for 10.49% of regional revenue and 2.83% of the global total, worth USD 0.058 billion in 2025 and USD 0.088 billion by 2034.
Mexico
3rd-largest in North America, growing 1.6×.
- In region 3 of 3
- Of region 9%
- Of global 2.4%
- Revenue $0.05B → $0.08B
Mexico is sized at USD 0.05 billion in 2025, rising to USD 0.078 billion by 2034; 2.44% of global revenue and 9.04% of North America. It is reported separately from the United States across every segmentation axis in the full report.
Europe Market Analysis
The 3rd-largest region covered — 2.7 points of share move elsewhere by 2034.
- Rank 3 of 5
- 2025 share 17%
- By 2034 14.3%
- Revenue $0.35B → $0.51B
17% of the global nematicides market sits in Europe in 2025, worth USD 0.349 billion rising to USD 0.508 billion in 2034. It is a mid-sized region on this axis, third by revenue throughout the period.
By 2034 the share stands at 14.3%, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.
The product type mix reported at global level applies here, with Fumigants the largest line at 36% of 2025 revenue and Microbial Biological Nematicides the fastest-growing at 12.24%. The full report breaks Europe out along every axis and by country.
Spain
The largest market in Europe, growing 1.5×.
- In region 1 of 3
- Of region 22.4%
- Of global 3.8%
- Revenue $0.08B → $0.12B
The largest single market in Europe is Spain, at USD 0.078 billion in 2025 and USD 0.118 billion in 2034. It accounts for 22.35% of regional revenue in the base year, the largest single share without dominating the region outright. Against regional totals of USD 0.349 billion in 2025 and USD 0.508 billion in 2034, it is the country the full report breaks out in detail.
Demand in Spain follows the product type mix reported at global level: Fumigants is the largest line at 36% of 2025 revenue, moving to 30.6% by 2034, while Microbial Biological Nematicides grows fastest at 12.24% and takes its share from 15% to 24.9%. Its 22.35% weight in Europe means those movements carry straight into the regional totals. Spain carries its own product type breakdown in the full report.
Spain applies the European Union framework for plant protection products. Active substances are approved at Union level through the European Food Safety Authority's risk assessment and a vote of member states. Each formulated product then needs national authorisation, which in Spain is handled by the Ministry of Agriculture, Fisheries and Food, following zonal assessment in the southern zone. Suppliers must meet the Union rules on classification, labelling and packaging of chemicals, and the national register lists permitted crops and uses. Professional users need training certification, and the sustainable use directive shapes how products are applied. Many older nematicidal actives have been withdrawn from the Union list.
Competition in Spain runs between the suppliers this study tracks: Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc. and Ishihara Sangyo Kaisha, Ltd.. Fumigants, at 36% of 2025 revenue, is where the volume sits, and Microbial Biological Nematicides, growing at 12.24%, is where position changes hands over the forecast period. A supplier weighted toward Europe is competing over a base of USD 0.349 billion in 2025 reaching USD 0.508 billion by 2034, 17% of global revenue at the start of that period.
France
2nd-largest in Europe, growing 1.4×.
- In region 2 of 3
- Of region 20.6%
- Of global 3.5%
- Revenue $0.07B → $0.10B
France is sized at USD 0.072 billion in 2025, rising to USD 0.104 billion by 2034; 3.51% of global revenue and 20.63% of Europe. It is reported separately from Spain across every segmentation axis in the full report.
Italy
3rd-largest in Europe, growing 1.5×.
- In region 3 of 3
- Of region 17.2%
- Of global 2.9%
- Revenue $0.06B → $0.09B
Within Europe, Italy accounts for 17.19% of regional revenue and 2.93% of the global total, worth USD 0.06 billion in 2025 and USD 0.088 billion by 2034.
Asia Pacific Market Analysis
The largest region covered, and the one gaining the most — it picks up 4.5 points of share by 2034, while revenue still grows 2.0×.
- Rank 1 of 5
- 2025 share 34%
- By 2034 38.5%
- Revenue $0.70B → $1.37B
In Asia Pacific, 34% of global revenue puts 2025 at USD 0.697 billion rising to USD 1.367 billion in 2034. That makes it the first-largest region covered, in 2025 and again in 2034.
Share climbs to 38.5% by 2034, because it outgrows the market's 6.29%; the revenue added here is disproportionate to where the region started.
Within the region the product type split tracks the global one; 36% of 2025 revenue in Fumigants, fastest growth of 12.24% in Microbial Biological Nematicides. The full report breaks Asia Pacific out along every axis and by country.
China
The largest market in Asia Pacific, growing 1.8×.
- In region 1 of 3
- Of region 32.3%
- Of global 11%
- Revenue $0.23B → $0.41B
The largest single market in Asia Pacific is China, at USD 0.225 billion in 2025 and USD 0.415 billion in 2034. It accounts for 32.28% of regional revenue in the base year, the largest single share without dominating the region outright. The region itself runs USD 0.697 billion to USD 1.367 billion over the same period, and this is the market carrying the country-level detail in the full report.
Demand in China follows the product type mix reported at global level: Fumigants is the largest line at 36% of 2025 revenue, moving to 30.6% by 2034, while Microbial Biological Nematicides grows fastest at 12.24% and takes its share from 15% to 24.9%. With 32.28% of Asia Pacific concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Revenue by product type for China is reported separately in the full report.
Pesticide registration in China is overseen by the Ministry of Agriculture and Rural Affairs, with its Institute for the Control of Agrochemicals running the technical review. Nematicides fall under the national Regulation on Pesticide Administration, which requires a registration certificate before production, import or sale. Applicants submit chemistry, toxicology, residue and field trial data, and foreign suppliers generally need local trials and a domestic representative. Manufacturers also require a production licence. Labels must follow the national pesticide labelling rules, including hazard pictograms, crop-specific directions and safety intervals. Maximum residue limits for foods are set separately under national food safety standards.
In China the field is Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc. and Ishihara Sangyo Kaisha, Ltd.. Two different problems sit on the same axis: holding Fumigants at 36% of 2025 revenue, and taking Microbial Biological Nematicides while it grows at 12.24%. The commercial size of that position is USD 0.697 billion in 2025, moving to USD 1.367 billion by 2034 across the forecast period.
India
2nd-largest in Asia Pacific, growing 2.0×.
- In region 2 of 3
- Of region 18.6%
- Of global 6.3%
- Revenue $0.13B → $0.26B
India is sized at USD 0.13 billion in 2025, rising to USD 0.262 billion by 2034; 6.34% of global revenue and 18.65% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.
Japan
3rd-largest in Asia Pacific, growing 1.4×.
- In region 3 of 3
- Of region 12.2%
- Of global 4.2%
- Revenue $0.09B → $0.12B
Japan is sized at USD 0.085 billion in 2025, rising to USD 0.118 billion by 2034; 4.15% of global revenue and 12.2% of Asia Pacific. It is reported separately from China across every segmentation axis in the full report.
Latin America Market Analysis
The 4th-largest region covered — it picks up 0.9 points of share by 2034, while revenue still grows 1.8×.
- Rank 4 of 5
- 2025 share 15%
- By 2034 15.9%
- Revenue $0.31B → $0.56B
In Latin America, 15% of global revenue puts 2025 at USD 0.307 billion and reaches USD 0.564 billion by 2034. That makes it the fourth-largest region covered, in 2025 and again in 2034.
Its share rises to 15.9% over the forecast period, so the region grows faster than the market's 6.29% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.
Within the region the product type split tracks the global one; 36% of 2025 revenue in Fumigants, fastest growth of 12.24% in Microbial Biological Nematicides. Latin America is reported axis by axis and country by country in the full study.
Brazil
The largest market in Latin America, growing 1.9×.
- In region 1 of 2
- Of region 55.4%
- Of global 8.3%
- Revenue $0.17B → $0.32B
The largest single market in Latin America is Brazil, at USD 0.17 billion in 2025 and USD 0.322 billion in 2034. Its 55.37% of base-year regional revenue leads the region, though enough sits elsewhere that Latin America is not a proxy for it. The region itself runs USD 0.307 billion to USD 0.564 billion over the same period, and this is the market carrying the country-level detail in the full report.
Brazil buys along the same lines as the market globally; Fumigants first at 36% of 2025 revenue and 30.6% in 2034, Microbial Biological Nematicides fastest at 12.24% on a share moving from 15% to 24.9%. Since 55.37% of Latin America's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Brazil carries its own product type breakdown in the full report.
Brazil regulates nematicides under the federal pesticide law through three bodies working together. The Ministry of Agriculture, Livestock and Supply handles agronomic efficacy and registration, the health regulator ANVISA assesses human toxicology, and the environmental agency IBAMA evaluates environmental risk. A product needs a registration from the ministry before it can be made, imported or sold. Recent reform changed review timelines and the way risk is assessed, while keeping the three-agency structure. Labels and leaflets must carry the prescribed toxicological class, hazard pictograms and instructions for use, and sales require an agronomic prescription issued by a qualified professional.
Competition in Brazil runs between the suppliers this study tracks: Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc. and Ishihara Sangyo Kaisha, Ltd.. Two different problems sit on the same axis: holding Fumigants at 36% of 2025 revenue, and taking Microbial Biological Nematicides while it grows at 12.24%. The commercial size of that position is USD 0.307 billion in 2025, moving to USD 0.564 billion by 2034 across the forecast period.
Argentina
2nd-largest in Latin America, growing 1.9×.
- In region 2 of 2
- Of region 11.4%
- Of global 1.7%
- Revenue $0.04B → $0.07B
1.71% of global revenue is generated in Argentina; USD 0.035 billion in 2025, reaching USD 0.066 billion in 2034, and 11.4% of Latin America.
Middle East and Africa Market Analysis
The 5th-largest region covered, holding its share flat through 2034, while revenue still grows 1.7×.
- Rank 5 of 5
- 2025 share 7%
- By 2034 7%
- Revenue $0.14B → $0.25B
7% of the global nematicides market sits in Middle East and Africa in 2025, worth USD 0.144 billion on the way to USD 0.249 billion by 2034. That makes it the fifth-largest region covered, in 2025 and again in 2034.
Share settles at 7% in 2034, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.
The product type mix reported at global level applies here, with Fumigants the largest line at 36% of 2025 revenue and Microbial Biological Nematicides the fastest-growing at 12.24%. Revenue for Middle East and Africa is broken out by every segmentation axis and by country in the full report.
South Africa
The largest market in Middle East and Africa, growing 1.8×.
- In region 1 of 2
- Of region 13.9%
- Of global 1%
- Revenue $0.02B → $0.04B
South Africa is the largest market within Middle East and Africa, generating USD 0.02 billion in 2025 and projected to reach USD 0.036 billion by 2034. At 13.89% of the region in 2025 it leads, but a majority of Middle East and Africa's revenue is generated in other markets. Set against USD 0.144 billion and USD 0.249 billion for the region, it is why this market, and not a smaller one, is the one reported in full.
The product type pattern in South Africa is the global one: 36% of 2025 revenue in Fumigants, 30.6% by 2034, against 12.24% growth in Microbial Biological Nematicides taking it from 15% to 24.9%. With 13.89% of Middle East and Africa concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Per-product type revenue for South Africa appears on its own in the full report.
Nematicides in South Africa are regulated under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, administered by the Department of Agriculture. A registrar assesses applications, and a product must be registered before it can be sold or imported. Suppliers submit data on efficacy, toxicology, residues and environmental behaviour, and the registration specifies approved crops and conditions of use. Labels must follow the prescribed format, with hazard statements, directions and precautions. Pest control operators and some applicators must be registered, and the act also covers storage and disposal. Imported products pass through the same registration route as local ones.
In South Africa the field is Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc. and Ishihara Sangyo Kaisha, Ltd.. Two different problems sit on the same axis: holding Fumigants at 36% of 2025 revenue, and taking Microbial Biological Nematicides while it grows at 12.24%. A supplier weighted toward Middle East and Africa is competing over a base of USD 0.144 billion in 2025 reaching USD 0.249 billion by 2034, 7% of global revenue at the start of that period.
Egypt
2nd-largest in Middle East and Africa, growing 1.8×.
- In region 2 of 2
- Of region 12.5%
- Of global 0.9%
- Revenue $0.02B → $0.03B
Egypt is sized at USD 0.018 billion in 2025, rising to USD 0.033 billion by 2034; 0.88% of global revenue and 12.5% of Middle East and Africa. It is reported separately from South Africa across every segmentation axis in the full report.
Download a free sample to see the full data tables and segment-level detail behind this analysis.
Report Coverage
This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by product type, mode of action, crop type, application method, formulation, target nematode, cultivation system, farming practice, distribution channel, end user, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.
Competitive Landscape
Scale in Fumigants and Growth in Microbial Biological Nematicides Set the Terms of Competition
Suppliers in scope: Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc. and Ishihara Sangyo Kaisha, Ltd..
Competition follows the product type split, not the regional one. Volume sits in Fumigants, USD 0.738 billion and 36% of 2025 revenue, 30.6% by 2034, which is also where an incumbent is hardest to dislodge. Share moves in Microbial Biological Nematicides, growing 12.24% against -0.06% for Organophosphates and Carbamates. The two rarely sit with the same supplier, and that is the reason a USD 2.05 billion market is not already consolidated.
Suppliers separate on formulation and manufacturing scale for soil-applied actives, registration experience across many countries, and reach through distributors and agri-retailers that hold the grower relationship. The largest players hold broad portfolios that pair fumigants and synthetic chemistries with seed-treatment and biological offers, and they can fund the data packages that new registrations demand. Regional and specialist suppliers compete on locally registered generics, price, technical support in specific crops, and fast-moving biological strains suited to organic and integrated programmes. Supply reliability of active ingredients and compliance with fumigant use rules also decide who keeps shelf position.
Geographic reach is the other axis of competition. Asia Pacific alone accounts for 34% of 2025 revenue, so a supplier absent there is absent from the largest part of the market whatever its position elsewhere; North America adds a further 27%.
Per-company profiles, financials, share and development history are in the full report and not here.
List of Key Nematicides Market Companies Profiled
30 companies profiled. Company profiles, including financials, product portfolios and recent developments, are part of the full report.
- Bayer AG(Germany)
- Syngenta Group(Switzerland)
- Corteva Agriscience(United States)
- BASF SE(Germany)
- FMC Corporation(United States)
- UPL Limited(India)
- Adama Ltd.(Israel)
- Nufarm Limited(Australia)
- Sumitomo Chemical Co., Ltd.(Japan)
- Albaugh LLC(United States)
- American Vanguard Corporation(United States)
- Certis Biologicals(United States)
- Marrone Bio Innovations (Bioceres Crop Solutions)(United States)
- Bioceres Crop Solutions Inc.(Argentina)
- Novozymes (Novonesis)(Denmark)
- Koppert Biological Systems(Netherlands)
- Rovensa Next
- Lallemand Inc.(Canada)
- Isagro S.p.A. (Gowan Company)(Italy)
- Arysta LifeScience (UPL)
- Sipcam Oxon S.p.A.(Italy)
- Rallis India Limited(India)
- Hebei Veyong Pharmaceutical Co., Ltd.(China)
- Shandong Weifang Rainbow Chemical Co., Ltd.(China)
- Lier Chemical Co., Ltd.(China)
- Pasteuria Bioscience (Syngenta)(United States)
- Eastman Chemical Company(United States)
- TriCal Inc.(United States)
- Nichino America, Inc.(United States)
- Ishihara Sangyo Kaisha, Ltd.(Japan)
Geographic Coverage
Every market below is broken out separately in the report.
North America
3Europe
8Asia Pacific
12Latin America
3Middle East and Africa
4Key Insights
Report Scope
Study parameters & segmentationThis study covers market size and forecasts over the 2020–2034 period, segmentation across 10 axes (Product Type, Mode of Action, Crop Type, Application Method, Formulation, Target Nematode, Cultivation System, Farming Practice, Distribution Channel, End User), regional analysis for 5 regions and their constituent countries, a competitive landscape profiling 30 key companies, and the research methodology behind every estimate.
Segmentation
10 axes + regionQuestions This Report Answers
6 questionsWhat is the market size and growth rate, globally and by region?
How is the market segmented, and which segments lead?
Which regions and countries are covered, and how do they compare?
What are the key drivers, restraints, opportunities and challenges?
Who are the leading companies operating in this market?
What trends are expected to shape the market through the forecast period?
Frequently Asked Questions
01What is the Nematicides Market projected to reach?
USD 3.55 USD Billion by 2034, CAGR 6.29%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
Asia Pacific leads with 34% of global revenue through 2034.
05Which segment leads the market?
Fumigants is the largest line by product type, at 36% of revenue in 2025.
06Who are the key companies profiled?
Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, FMC Corporation, UPL Limited, Adama Ltd., Nufarm Limited, Sumitomo Chemical Co., Ltd., Albaugh LLC, American Vanguard Corporation, Certis Biologicals, Marrone Bio Innovations (Bioceres Crop Solutions), Bioceres Crop Solutions Inc., Novozymes (Novonesis), Koppert Biological Systems, Rovensa Next, Lallemand Inc., Isagro S.p.A. (Gowan Company), Arysta LifeScience (UPL), Sipcam Oxon S.p.A., Rallis India Limited, Hebei Veyong Pharmaceutical Co., Ltd., Shandong Weifang Rainbow Chemical Co., Ltd., Lier Chemical Co., Ltd., Pasteuria Bioscience (Syngenta), Eastman Chemical Company, TriCal Inc., Nichino America, Inc., Ishihara Sangyo Kaisha, Ltd.. Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
Why choose CDI
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.